To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Molecular Diagnostics in Cancer Testing
Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. This TriMark Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.
Order market study
Order the market study at markt-studie.de
This is where you can add this market study to your personal favourites.
- 1PT Bristol-Myers Squibb Indonesia Tbk (SQBI) - Financial and Strategic SWOT Analysis Review
- 2Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review
- 3Herbalife Ltd. (HLF) - Financial and Strategic SWOT Analysis Review
- 4Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review
- 5Asiri Hospital PLC (ASIR) - Financial and Strategic SWOT Analysis Review
- 6Shanghai Kehua Bio-engineering Co., Ltd. (002022) - Financial and Strategic SWOT Analysis Review
- 7Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
- 8Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic SWOT Analysis Review
- 9Cambodia Pharmaceuticals and Healthcare Report Q1 2012
- 10Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients